ZYRTEC-D Allergy Plus Congestion is a Oral Tablet, Film Coated, Extended Release in the Human Otc Drug category. It is labeled and distributed by Johnson & Johnson Consumer Inc., Mcneil Consumer Healthcare Division. The primary component is Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride.
| Product ID | 50580-728_ce2ccd3c-723e-1164-e053-2a95a90abb5b |
| NDC | 50580-728 |
| Product Type | Human Otc Drug |
| Proprietary Name | ZYRTEC-D Allergy Plus Congestion |
| Generic Name | Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021150 |
| Labeler Name | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
| Substance Name | CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2008-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021150 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-01-01 |
| Marketing End Date | 2015-12-07 |
| Marketing Category | NDA |
| Application Number | NDA021150 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-01-01 |
| Marketing Category | NDA |
| Application Number | NDA021150 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2008-01-01 |
| Marketing Category | NDA |
| Application Number | NDA021150 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-01-01 |
| Marketing End Date | 2015-12-07 |
| Marketing Category | NDA |
| Application Number | NDA021150 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2008-01-01 |
| Marketing End Date | 2015-12-07 |
| Marketing Category | NDA |
| Application Number | NDA021150 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-01-01 |
| Ingredient | Strength |
|---|---|
| CETIRIZINE HYDROCHLORIDE | 5 mg/1 |
| SPL SET ID: | 1e8eb279-3522-40e4-8062-06b5354f0d29 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70677-0146 | all day allergy-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 49035-982 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 51660-940 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 68016-531 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 69842-994 | Allergy Relief-D | Cetirizine hydrochloride and pseudoephedrine hydrochloride |
| 70000-0163 | Allergy relief-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 62756-915 | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 63868-964 | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 0363-0989 | Wal-Zyr D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
| 50580-728 | ZYRTEC-D | Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZYRTEC-D 76061430 2535836 Live/Registered |
UCB BIOPHARMA SPRL 2000-05-23 |
![]() ZYRTEC-D 75111269 not registered Dead/Abandoned |
UCB, Societe Anonyme 1996-05-29 |